U.S. Markets close in 3 hrs 22 mins
  • Conference Spotlights Drug Giant Donnybrooks In Cancer Treatments
    Investor's Business Daily11 days ago

    Conference Spotlights Drug Giant Donnybrooks In Cancer Treatments

    Preliminary data highlights breast, ovarian, lung and skin cancer data to presented during the American Society of Clinical Oncology meeting next month.

  • Capital Cube11 days ago

    TESARO, Inc. – Value Analysis (NASDAQ:TSRO) : May 18, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives TESARO, Inc. a score of 25. Our analysis is based on comparing TESARO, Inc. with the following peers – Clovis Oncology, Inc., ZIOPHARM Oncology, Inc., Amgen Inc., Cerulean Pharma, Inc., Merck & Co., Inc., Bristol-Myers Squibb Company, Insys Therapeutics, Inc. and Pfizer Inc. (CLVS-US, ZIOP-US, AMGN-US, CERU-US, ... Read more (Read more...)

  • Did AstraZeneca Rival Just Launch A Potential Blockbuster Drug?
    Investor's Business Daily12 days ago

    Did AstraZeneca Rival Just Launch A Potential Blockbuster Drug?

    An analyst upgraded Clovis ahead of a key study for its ovarian cancer drug, which he said holds up against another from AstraZeneca.